The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Miofen 400mg Film-coated Tablet

Alter PharmaPA22983/001/002

Main Information

Trade NameMiofen 400mg Film-coated Tablet
Active SubstancesIbuprofen
Dosage FormFilm-coated tablet
Licence HolderAlter Pharma
Licence NumberPA22983/001/002

Group Information

ATC CodeM01AE Propionic acid derivatives
M01AE01 ibuprofen


License statusWithdrawn
Withdrawn Date27/06/2024
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThe applicant's commitment dated 17/07/15 that the product names in the Miofen range will be amended prior to marketing to differentiate between prescription and non-prescription presentations is noted.
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back